<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-01-11" modified="2017-05-10" version="166">
<accession>Q9UBP0</accession>
<accession>A7E2A7</accession>
<accession>Q9UPR9</accession>
<name>SPAST_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="9 78">Spastin</fullName>
<ecNumber evidence="9 36 39 44 47 49 64">3.6.4.3</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Spastic paraplegia 4 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="9 85">SPAST</name>
<name type="synonym">ADPSP</name>
<name type="synonym">FSP2</name>
<name type="synonym" evidence="77">KIAA1083</name>
<name type="synonym" evidence="9">SPG4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="296" last="303">
<title>Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.</title>
<authorList>
<person name="Hazan J."/>
<person name="Fonknechten N."/>
<person name="Mavel D."/>
<person name="Paternotte C."/>
<person name="Samson D."/>
<person name="Artiguenave F."/>
<person name="Davoine C.-S."/>
<person name="Cruaud C."/>
<person name="Durr A."/>
<person name="Wincker P."/>
<person name="Brottier P."/>
<person name="Cattolico L."/>
<person name="Barbe V."/>
<person name="Burgunder J.-M."/>
<person name="Prud'homme J.-F."/>
<person name="Brice A."/>
<person name="Fontaine B."/>
<person name="Heilig R."/>
<person name="Weissenbach J."/>
</authorList>
<dbReference type="PubMed" id="10610178"/>
<dbReference type="DOI" id="10.1038/15472"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>VARIANTS SPG4 CYS-362; TYR-448 AND CYS-499</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="DNA Res." volume="6" first="197" last="205">
<title>Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Kikuno R."/>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Hirosawa M."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10470851"/>
<dbReference type="DOI" id="10.1093/dnares/6.3.197"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Hum. Mol. Genet." volume="11" first="153" last="163">
<title>Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics.</title>
<authorList>
<person name="Errico A."/>
<person name="Ballabio A."/>
<person name="Rugarli E.I."/>
</authorList>
<dbReference type="PubMed" id="11809724"/>
<dbReference type="DOI" id="10.1093/hmg/11.2.153"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS SPG4 ARG-370; CYS-381; LYS-386; ARG-388; VAL-426; TYR-448; LEU-460; CYS-499 AND VAL-556</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Genomics" volume="81" first="437" last="441">
<title>The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia.</title>
<authorList>
<person name="Ciccarelli F.D."/>
<person name="Proukakis C."/>
<person name="Patel H."/>
<person name="Cross H."/>
<person name="Azam S."/>
<person name="Patton M.A."/>
<person name="Bork P."/>
<person name="Crosby A.H."/>
</authorList>
<dbReference type="PubMed" id="12676568"/>
<dbReference type="DOI" id="10.1016/S0888-7543(03)00011-9"/>
</citation>
<scope>DOMAIN MIT</scope>
<scope>PROBABLE FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="318" first="1079" last="1084">
<title>Identification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter system.</title>
<authorList>
<person name="Beetz C."/>
<person name="Brodhun M."/>
<person name="Moutzouris K."/>
<person name="Kiehntopf M."/>
<person name="Berndt A."/>
<person name="Lehnert D."/>
<person name="Deufel T."/>
<person name="Bastmeyer M."/>
<person name="Schickel J."/>
</authorList>
<dbReference type="PubMed" id="15147984"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.03.195"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="2121" last="2132">
<title>Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon.</title>
<authorList>
<person name="Errico A."/>
<person name="Claudiani P."/>
<person name="D'Addio M."/>
<person name="Rugarli E.I."/>
</authorList>
<dbReference type="PubMed" id="15269182"/>
<dbReference type="DOI" id="10.1093/hmg/ddh223"/>
</citation>
<scope>INTERACTION WITH SSNA1 AND MICROTUBULES</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Exp. Cell Res." volume="309" first="358" last="369">
<title>Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus.</title>
<authorList>
<person name="Claudiani P."/>
<person name="Riano E."/>
<person name="Errico A."/>
<person name="Andolfi G."/>
<person name="Rugarli E.I."/>
</authorList>
<dbReference type="PubMed" id="16026783"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2005.06.009"/>
</citation>
<scope>ALTERNATIVE INITIATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR EXPORT SIGNALS</scope>
<scope>MUTAGENESIS OF MET-1 AND MET-87</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="19" last="38">
<title>The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B.</title>
<authorList>
<person name="Reid E."/>
<person name="Connell J.W."/>
<person name="Edwards T.L."/>
<person name="Duley S."/>
<person name="Brown S.E."/>
<person name="Sanderson C.M."/>
</authorList>
<dbReference type="PubMed" id="15537668"/>
<dbReference type="DOI" id="10.1093/hmg/ddi003"/>
</citation>
<scope>INTERACTION WITH CHMP1B</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="168" first="599" last="606">
<title>Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing.</title>
<authorList>
<person name="Evans K.J."/>
<person name="Gomes E.R."/>
<person name="Reisenweber S.M."/>
<person name="Gundersen G.G."/>
<person name="Lauring B.P."/>
</authorList>
<dbReference type="PubMed" id="15716377"/>
<dbReference type="DOI" id="10.1083/jcb.200409058"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INTERACTION WITH MICROTUBULES</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-388 AND GLU-442</scope>
<scope>CHARACTERIZATION OF VARIANTS SPG4 LYS-344; LYS-347; LYS-386; ARG-388 AND CYS-499</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Neurochem." volume="95" first="1411" last="1420">
<title>Human spastin has multiple microtubule-related functions.</title>
<authorList>
<person name="Salinas S."/>
<person name="Carazo-Salas R.E."/>
<person name="Proukakis C."/>
<person name="Cooper J.M."/>
<person name="Weston A.E."/>
<person name="Schiavo G."/>
<person name="Warner T.T."/>
</authorList>
<dbReference type="PubMed" id="16219033"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2005.03472.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ASSOCIATION WITH MICROTUBULES</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Neurogenetics" volume="6" first="135" last="141">
<title>Subcellular localization of spastin: implications for the pathogenesis of hereditary spastic paraplegia.</title>
<authorList>
<person name="Svenson I.K."/>
<person name="Kloos M.T."/>
<person name="Jacon A."/>
<person name="Gallione C."/>
<person name="Horton A.C."/>
<person name="Pericak-Vance M.A."/>
<person name="Ehlers M.D."/>
<person name="Marchuk D.A."/>
</authorList>
<dbReference type="PubMed" id="15891913"/>
<dbReference type="DOI" id="10.1007/s10048-005-0219-2"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT SPG4 ARG-388</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Am. J. Hum. Genet." volume="79" first="351" last="357">
<title>ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia.</title>
<authorList>
<person name="Mannan A.U."/>
<person name="Krawen P."/>
<person name="Sauter S.M."/>
<person name="Boehm J."/>
<person name="Chronowska A."/>
<person name="Paulus W."/>
<person name="Neesen J."/>
<person name="Engel W."/>
</authorList>
<dbReference type="PubMed" id="16826525"/>
<dbReference type="DOI" id="10.1086/504927"/>
</citation>
<scope>INTERACTION WITH ZFYVE27</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Hum. Mol. Genet." volume="15" first="307" last="318">
<title>Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners.</title>
<authorList>
<person name="Sanderson C.M."/>
<person name="Connell J.W."/>
<person name="Edwards T.L."/>
<person name="Bright N.A."/>
<person name="Duley S."/>
<person name="Thompson A."/>
<person name="Luzio J.P."/>
<person name="Reid E."/>
</authorList>
<dbReference type="PubMed" id="16339213"/>
<dbReference type="DOI" id="10.1093/hmg/ddi447"/>
</citation>
<scope>INTERACTION WITH ATL1</scope>
<scope>CHARACTERIZATION OF VARIANT SPG4 ARG-388</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Neurogenetics" volume="7" first="93" last="103">
<title>Spastin, the most commonly mutated protein in hereditary spastic paraplegia interacts with Reticulon 1 an endoplasmic reticulum protein.</title>
<authorList>
<person name="Mannan A.U."/>
<person name="Boehm J."/>
<person name="Sauter S.M."/>
<person name="Rauber A."/>
<person name="Byrne P.C."/>
<person name="Neesen J."/>
<person name="Engel W."/>
</authorList>
<dbReference type="PubMed" id="16602018"/>
<dbReference type="DOI" id="10.1007/s10048-006-0034-4"/>
</citation>
<scope>INTERACTION WITH RTN1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="10666" last="10671">
<title>Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance.</title>
<authorList>
<person name="Evans K.J."/>
<person name="Keller C."/>
<person name="Pavur K."/>
<person name="Glasgow K."/>
<person name="Conn B."/>
<person name="Lauring B.P."/>
</authorList>
<dbReference type="PubMed" id="16815977"/>
<dbReference type="DOI" id="10.1073/pnas.0510863103"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH ATL1</scope>
<scope>MUTAGENESIS OF GLU-442</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="176" first="995" last="1005">
<title>Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing.</title>
<authorList>
<person name="White S.R."/>
<person name="Evans K.J."/>
<person name="Lary J."/>
<person name="Cole J.L."/>
<person name="Lauring B.P."/>
</authorList>
<dbReference type="PubMed" id="17389232"/>
<dbReference type="DOI" id="10.1083/jcb.200610072"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>HOMOHEXAMERIZATION</scope>
<scope>INTERACTION WITH TUBULIN AND MICROTUBULES</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-415; GLU-442; ARG-451 AND ALA-457</scope>
<scope>CHARACTERIZATION OF VARIANT SPG4 TYR-448</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="BMC Biol." volume="6" first="31" last="31">
<title>A cryptic promoter in the first exon of the SPG4 gene directs the synthesis of the 60-kDa spastin isoform.</title>
<authorList>
<person name="Mancuso G."/>
<person name="Rugarli E.I."/>
</authorList>
<dbReference type="PubMed" id="18613979"/>
<dbReference type="DOI" id="10.1186/1741-7007-6-31"/>
</citation>
<scope>ALTERNATIVE PROMOTER USAGE</scope>
<scope>CHARACTERIZATION OF VARIANT LEU-44</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Neurochem." volume="106" first="613" last="624">
<title>Spastin oligomerizes into a hexamer and the mutant spastin (E442Q) redistribute the wild-type spastin into filamentous microtubule.</title>
<authorList>
<person name="Pantakani D.V.K."/>
<person name="Swapna L.S."/>
<person name="Srinivasan N."/>
<person name="Mannan A.U."/>
</authorList>
<dbReference type="PubMed" id="18410514"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2008.05414.x"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>HOMOHEXAMERIZATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF GLU-442</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268 AND THR-306</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Traffic" volume="10" first="42" last="56">
<title>Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion.</title>
<authorList>
<person name="Connell J.W."/>
<person name="Lindon C."/>
<person name="Luzio J.P."/>
<person name="Reid E."/>
</authorList>
<dbReference type="PubMed" id="19000169"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2008.00847.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1 AND 3)</scope>
<scope>CHARACTERIZATION OF VARIANT SPG4 ARG-388</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="J. Clin. Invest." volume="120" first="1097" last="1110">
<title>Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network.</title>
<authorList>
<person name="Park S.H."/>
<person name="Zhu P.P."/>
<person name="Parker R.L."/>
<person name="Blackstone C."/>
</authorList>
<dbReference type="PubMed" id="20200447"/>
<dbReference type="DOI" id="10.1172/JCI40979"/>
</citation>
<scope>INTERACTION WITH REEP1</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1 AND 3)</scope>
<scope>TOPOLOGY (ISOFORM 1)</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="J. Cell Biol." volume="189" first="945" last="954">
<title>Tubulin polyglutamylation stimulates spastin-mediated microtubule severing.</title>
<authorList>
<person name="Lacroix B."/>
<person name="van Dijk J."/>
<person name="Gold N.D."/>
<person name="Guizetti J."/>
<person name="Aldrian-Herrada G."/>
<person name="Rogowski K."/>
<person name="Gerlich D.W."/>
<person name="Janke C."/>
</authorList>
<dbReference type="PubMed" id="20530212"/>
<dbReference type="DOI" id="10.1083/jcb.201001024"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Science" volume="331" first="1616" last="1620">
<title>Cortical constriction during abscission involves helices of ESCRT-III-dependent filaments.</title>
<authorList>
<person name="Guizetti J."/>
<person name="Schermelleh L."/>
<person name="Maentler J."/>
<person name="Maar S."/>
<person name="Poser I."/>
<person name="Leonhardt H."/>
<person name="Mueller-Reichert T."/>
<person name="Gerlich D.W."/>
</authorList>
<dbReference type="PubMed" id="21310966"/>
<dbReference type="DOI" id="10.1126/science.1201847"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="26278" last="26290">
<title>Subunit Interactions and cooperativity in the microtubule-severing AAA ATPase spastin.</title>
<authorList>
<person name="Eckert T."/>
<person name="Link S."/>
<person name="Le D.T."/>
<person name="Sobczak J.P."/>
<person name="Gieseke A."/>
<person name="Richter K."/>
<person name="Woehlke G."/>
</authorList>
<dbReference type="PubMed" id="22637577"/>
<dbReference type="DOI" id="10.1074/jbc.M111.291898"/>
</citation>
<scope>HOMOHEXAMERIZATION</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>KINETIC PARAMETERS</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>COOPERATIVITY</scope>
<scope>MUTAGENESIS OF GLU-442</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="J. Clin. Invest." volume="122" first="538" last="544">
<title>Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12.</title>
<authorList>
<person name="Montenegro G."/>
<person name="Rebelo A.P."/>
<person name="Connell J."/>
<person name="Allison R."/>
<person name="Babalini C."/>
<person name="D'Aloia M."/>
<person name="Montieri P."/>
<person name="Schule R."/>
<person name="Ishiura H."/>
<person name="Price J."/>
<person name="Strickland A."/>
<person name="Gonzalez M.A."/>
<person name="Baumbach-Reardon L."/>
<person name="Deconinck T."/>
<person name="Huang J."/>
<person name="Bernardi G."/>
<person name="Vance J.M."/>
<person name="Rogers M.T."/>
<person name="Tsuji S."/>
<person name="De Jonghe P."/>
<person name="Pericak-Vance M.A."/>
<person name="Schols L."/>
<person name="Orlacchio A."/>
<person name="Reid E."/>
<person name="Zuchner S."/>
</authorList>
<dbReference type="PubMed" id="22232211"/>
<dbReference type="DOI" id="10.1172/JCI60560"/>
</citation>
<scope>INTERACTION WITH RTN2</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E50161" last="E50161">
<title>Spastin's microtubule-binding properties and comparison to katanin.</title>
<authorList>
<person name="Eckert T."/>
<person name="Le D.T."/>
<person name="Link S."/>
<person name="Friedmann L."/>
<person name="Woehlke G."/>
</authorList>
<dbReference type="PubMed" id="23272056"/>
<dbReference type="DOI" id="10.1371/journal.pone.0050161"/>
</citation>
<scope>INTERACTION WITH MICROTUBULES</scope>
<scope>OLIGOMERIZATION</scope>
<scope>MUTAGENESIS OF 310-LYS--LYS-312 AND GLU-442</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="FEBS J." volume="280" first="3868" last="3877">
<title>The nucleotide cycle of spastin correlates with its microtubule-binding properties.</title>
<authorList>
<person name="Wen M."/>
<person name="Wang C."/>
</authorList>
<dbReference type="PubMed" id="23745751"/>
<dbReference type="DOI" id="10.1111/febs.12385"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF GLU-442 AND CYS-448</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="J. Cell Biol." volume="202" first="527" last="543">
<title>An ESCRT-spastin interaction promotes fission of recycling tubules from the endosome.</title>
<authorList>
<person name="Allison R."/>
<person name="Lumb J.H."/>
<person name="Fassier C."/>
<person name="Connell J.W."/>
<person name="Ten Martin D."/>
<person name="Seaman M.N."/>
<person name="Hazan J."/>
<person name="Reid E."/>
</authorList>
<dbReference type="PubMed" id="23897888"/>
<dbReference type="DOI" id="10.1083/jcb.201211045"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1 AND 3)</scope>
<scope>INTERACTION WITH IST1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245; SER-268 AND SER-597</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="14954" last="14959">
<title>Protrudin binds atlastins and endoplasmic reticulum-shaping proteins and regulates network formation.</title>
<authorList>
<person name="Chang J."/>
<person name="Lee S."/>
<person name="Blackstone C."/>
</authorList>
<dbReference type="PubMed" id="23969831"/>
<dbReference type="DOI" id="10.1073/pnas.1307391110"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ZFYVE27</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Nature" volume="522" first="231" last="235">
<title>Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing.</title>
<authorList>
<person name="Vietri M."/>
<person name="Schink K.O."/>
<person name="Campsteijn C."/>
<person name="Wegner C.S."/>
<person name="Schultz S.W."/>
<person name="Christ L."/>
<person name="Thoresen S.B."/>
<person name="Brech A."/>
<person name="Raiborg C."/>
<person name="Stenmark H."/>
</authorList>
<dbReference type="PubMed" id="26040712"/>
<dbReference type="DOI" id="10.1038/nature14408"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1 AND 3)</scope>
<scope>INTERACTION WITH IST1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="PLoS Genet." volume="11" first="E1005149" last="E1005149">
<title>Spastin binds to lipid droplets and affects lipid metabolism.</title>
<authorList>
<person name="Papadopoulos C."/>
<person name="Orso G."/>
<person name="Mancuso G."/>
<person name="Herholz M."/>
<person name="Gumeni S."/>
<person name="Tadepalle N."/>
<person name="Juengst C."/>
<person name="Tzschichholz A."/>
<person name="Schauss A."/>
<person name="Hoening S."/>
<person name="Trifunovic A."/>
<person name="Daga A."/>
<person name="Rugarli E.I."/>
</authorList>
<dbReference type="PubMed" id="25875445"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1005149"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF ARG-65 AND 81-ARG--ARG-84</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2016" name="Cell" volume="164" first="911" last="921">
<title>Graded control of microtubule severing by tubulin glutamylation.</title>
<authorList>
<person name="Valenstein M.L."/>
<person name="Roll-Mecak A."/>
</authorList>
<dbReference type="PubMed" id="26875866"/>
<dbReference type="DOI" id="10.1016/j.cell.2016.01.019"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="Nat. Struct. Mol. Biol." volume="15" first="1278" last="1286">
<title>Structural basis for midbody targeting of spastin by the ESCRT-III protein CHMP1B.</title>
<authorList>
<person name="Yang D."/>
<person name="Rismanchi N."/>
<person name="Renvoise B."/>
<person name="Lippincott-Schwartz J."/>
<person name="Blackstone C."/>
<person name="Hurley J.H."/>
</authorList>
<dbReference type="PubMed" id="18997780"/>
<dbReference type="DOI" id="10.1038/nsmb.1512"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 112-196 IN COMPLEX WITH CHMP1B</scope>
<scope>INTERACTION WITH CHMP1B</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF HIS-120 AND PHE-124</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="J. Struct. Biol." volume="179" first="133" last="137">
<title>Crystal structure of the human spastin AAA domain.</title>
<authorList>
<person name="Taylor J.L."/>
<person name="White S.R."/>
<person name="Lauring B."/>
<person name="Kull F.J."/>
</authorList>
<dbReference type="PubMed" id="22446388"/>
<dbReference type="DOI" id="10.1016/j.jsb.2012.03.002"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 228-616 OF MUTANT GLN-442</scope>
<scope>MUTAGENESIS OF GLU-442</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2000" name="Eur. J. Hum. Genet." volume="8" first="771" last="776">
<title>Hereditary spastic paraplegia caused by mutations in the SPG4 gene.</title>
<authorList>
<person name="Buerger J."/>
<person name="Fonknechten N."/>
<person name="Hoeltzenbein M."/>
<person name="Neumann L."/>
<person name="Bratanoff E."/>
<person name="Hazan J."/>
<person name="Reis A."/>
</authorList>
<dbReference type="PubMed" id="11039577"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200528"/>
</citation>
<scope>VARIANT SPG4 GLY-441</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="637" last="644">
<title>Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia.</title>
<authorList>
<person name="Fonknechten N."/>
<person name="Mavel D."/>
<person name="Byrne P."/>
<person name="Davoine C.-S."/>
<person name="Cruaud C."/>
<person name="Bonsch D."/>
<person name="Samson D."/>
<person name="Coutinho P."/>
<person name="Hutchinson M."/>
<person name="McMonagle P."/>
<person name="Burgunder J.-M."/>
<person name="Tartaglione A."/>
<person name="Heinzlef O."/>
<person name="Feki I."/>
<person name="Deufel T."/>
<person name="Parfrey N."/>
<person name="Brice A."/>
<person name="Fontaine B."/>
<person name="Prud'homme J.-F."/>
<person name="Weissenbach J."/>
<person name="Duerr A."/>
<person name="Hazan J."/>
</authorList>
<dbReference type="PubMed" id="10699187"/>
<dbReference type="DOI" id="10.1093/hmg/9.4.637"/>
</citation>
<scope>VARIANTS SPG4 CYS-362; ARG-370; CYS-381; LYS-386; ARG-388; VAL-426; TYR-448; LEU-460; CYS-499; ASN-555 AND VAL-556</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2000" name="J. Med. Genet." volume="37" first="759" last="765">
<title>Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis.</title>
<authorList>
<person name="Lindsey J.C."/>
<person name="Lusher M.E."/>
<person name="McDermott C.J."/>
<person name="White K.D."/>
<person name="Reid E."/>
<person name="Rubinsztein D.C."/>
<person name="Bashir R."/>
<person name="Hazan J."/>
<person name="Shaw P.J."/>
<person name="Bushby K.M.D."/>
</authorList>
<dbReference type="PubMed" id="11015453"/>
<dbReference type="DOI" id="10.1136/jmg.37.10.759"/>
</citation>
<scope>VARIANTS SPG4 GLY-424 AND HIS-584</scope>
<scope>VARIANT LEU-44</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2000" name="Neurology" volume="55" first="1388" last="1390">
<title>Novel mutations in spastin gene and absence of correlation with age at onset of symptoms.</title>
<authorList>
<person name="Hentati A."/>
<person name="Deng H.-X."/>
<person name="Zhai H."/>
<person name="Chen W."/>
<person name="Yang Y."/>
<person name="Hung W.-Y."/>
<person name="Azim A.C."/>
<person name="Bohlega S."/>
<person name="Tandan R."/>
<person name="Warner C."/>
<person name="Laing N.G."/>
<person name="Cambi F."/>
<person name="Mitsumoto H."/>
<person name="Roos R.P."/>
<person name="Boustany R.-M.N."/>
<person name="Ben-Hamida M."/>
<person name="Hentati F."/>
<person name="Siddique T."/>
</authorList>
<dbReference type="PubMed" id="11087788"/>
<dbReference type="DOI" id="10.1212/WNL.55.9.1388"/>
</citation>
<scope>VARIANTS SPG4 PHE-436 AND ASP-559</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2001" name="Am. J. Hum. Genet." volume="68" first="1077" last="1085">
<title>Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia.</title>
<authorList>
<person name="Svenson I.K."/>
<person name="Ashley-Koch A.E."/>
<person name="Gaskell P.C."/>
<person name="Riney T.J."/>
<person name="Cumming W.J.K."/>
<person name="Kingston H.M."/>
<person name="Hogan E.L."/>
<person name="Boustany R.-M.N."/>
<person name="Vance J.M."/>
<person name="Nance M.A."/>
<person name="Pericak-Vance M.A."/>
<person name="Marchuk D.A."/>
</authorList>
<dbReference type="PubMed" id="11309678"/>
<dbReference type="DOI" id="10.1086/320111"/>
</citation>
<scope>VARIANTS SPG4 CYS-499 AND GLY-562</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2002" name="Acta Neurol. Scand." volume="106" first="387" last="391">
<title>A Japanese SPG4 family with a novel missense mutation of the SPG4 gene: intrafamilial variability in age at onset and clinical severity.</title>
<authorList>
<person name="Namekawa M."/>
<person name="Takiyama Y."/>
<person name="Sakoe K."/>
<person name="Nagaki H."/>
<person name="Shimazaki H."/>
<person name="Yoshimura M."/>
<person name="Ikeguchi K."/>
<person name="Nakano I."/>
<person name="Nishizawa M."/>
</authorList>
<dbReference type="PubMed" id="12460147"/>
<dbReference type="DOI" id="10.1034/j.1600-0404.2002.01254.x"/>
</citation>
<scope>VARIANT SPG4 VAL-485</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2002" name="Arch. Neurol." volume="59" first="281" last="286">
<title>Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia.</title>
<authorList>
<person name="Meijer I.A."/>
<person name="Hand C.K."/>
<person name="Cossette P."/>
<person name="Figlewicz D.A."/>
<person name="Rouleau G.A."/>
</authorList>
<dbReference type="PubMed" id="11843700"/>
<dbReference type="DOI" id="10.1001/archneur.59.2.281"/>
</citation>
<scope>VARIANTS SPG4 LEU-399; VAL-426; LEU-489; ASP-559 AND GLN-562</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="127" last="132">
<title>Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia.</title>
<authorList>
<person name="Sauter S.M."/>
<person name="Miterski B."/>
<person name="Klimpe S."/>
<person name="Boensch D."/>
<person name="Schoels L."/>
<person name="Visbeck A."/>
<person name="Papke T."/>
<person name="Hopf H.C."/>
<person name="Engel W."/>
<person name="Deufel T."/>
<person name="Epplen J.T."/>
<person name="Neesen J."/>
</authorList>
<dbReference type="PubMed" id="12124993"/>
<dbReference type="DOI" id="10.1002/humu.10105"/>
</citation>
<scope>VARIANTS SPG4 ARG-407; TYR-551 AND ILE-615</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2002" name="J. Med. Genet." volume="39" first="E46" last="E46">
<title>Spastin gene mutation in Japanese with hereditary spastic paraplegia.</title>
<authorList>
<person name="Yabe I."/>
<person name="Sasaki H."/>
<person name="Tashiro K."/>
<person name="Matsuura T."/>
<person name="Takegami T."/>
<person name="Satoh T."/>
</authorList>
<dbReference type="PubMed" id="12161613"/>
<dbReference type="DOI" id="10.1136/jmg.39.8.e46"/>
</citation>
<scope>VARIANTS SPG4 LYS-347; ARG-388 AND CYS-499</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2002" name="J. Neurol." volume="249" first="200" last="205">
<title>Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia.</title>
<authorList>
<person name="Patrono C."/>
<person name="Casali C."/>
<person name="Tessa A."/>
<person name="Cricchi F."/>
<person name="Fortini D."/>
<person name="Carrozzo R."/>
<person name="Siciliano G."/>
<person name="Bertini E."/>
<person name="Santorelli F.M."/>
</authorList>
<dbReference type="PubMed" id="11985387"/>
<dbReference type="DOI" id="10.1007/PL00007865"/>
</citation>
<scope>VARIANT SPG4 ASP-512</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2002" name="J. Neurol. Sci." volume="201" first="65" last="69">
<title>Three novel spastin (SPG4) mutations in families with autosomal dominant hereditary spastic paraplegia.</title>
<authorList>
<person name="Proukakis C."/>
<person name="Hart P.E."/>
<person name="Cornish A."/>
<person name="Warner T.T."/>
<person name="Crosby A.H."/>
</authorList>
<dbReference type="PubMed" id="12163196"/>
<dbReference type="DOI" id="10.1016/S0022-510X(02)00192-2"/>
</citation>
<scope>VARIANT SPG4 PHE-404 DEL</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2002" name="J. Hum. Genet." volume="47" first="473" last="477">
<title>A novel missense mutation (I344K) in the SPG4gene in a Korean family with autosomal-dominant hereditary spastic paraplegia.</title>
<authorList>
<person name="Ki C.S."/>
<person name="Lee W.Y."/>
<person name="Han do H."/>
<person name="Sung D.H."/>
<person name="Lee K.B."/>
<person name="Lee K.A."/>
<person name="Cho S.S."/>
<person name="Cho S."/>
<person name="Hwang H."/>
<person name="Sohn K.M."/>
<person name="Choi Y.J."/>
<person name="Kim J.W."/>
</authorList>
<dbReference type="PubMed" id="12202986"/>
<dbReference type="DOI" id="10.1007/s100380200068"/>
</citation>
<scope>VARIANT SPG4 LYS-344</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="21" first="170" last="170">
<title>Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene.</title>
<authorList>
<person name="Proukakis C."/>
<person name="Auer-Grumbach M."/>
<person name="Wagner K."/>
<person name="Wilkinson P.A."/>
<person name="Reid E."/>
<person name="Patton M.A."/>
<person name="Warner T.T."/>
<person name="Crosby A.H."/>
</authorList>
<dbReference type="PubMed" id="12552568"/>
<dbReference type="DOI" id="10.1002/humu.9108"/>
</citation>
<scope>VARIANT SPG4 LEU-503</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2003" name="Eur. J. Hum. Genet." volume="11" first="710" last="713">
<title>Novel spastin mutations and their expression analysis in two Italian families.</title>
<authorList>
<person name="Molon A."/>
<person name="Montagna P."/>
<person name="Angelini C."/>
<person name="Pegoraro E."/>
</authorList>
<dbReference type="PubMed" id="12939659"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5201027"/>
</citation>
<scope>VARIANT SPG4 PRO-534</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2004" name="Arch. Neurol." volume="61" first="49" last="55">
<title>Three novel mutations of the spastin gene in Chinese patients with hereditary spastic paraplegia.</title>
<authorList>
<person name="Tang B."/>
<person name="Zhao G."/>
<person name="Xia K."/>
<person name="Pan Q."/>
<person name="Luo W."/>
<person name="Shen L."/>
<person name="Long Z."/>
<person name="Dai H."/>
<person name="Zi X."/>
<person name="Jiang H."/>
</authorList>
<dbReference type="PubMed" id="14732620"/>
<dbReference type="DOI" id="10.1001/archneur.61.1.49"/>
</citation>
<scope>VARIANTS SPG4 GLN-378; VAL-390 AND LEU-515 DEL</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2004" name="Arch. Neurol." volume="61" first="849" last="855">
<title>Hereditary spastic paraplegia: clinical genetic study of 15 families.</title>
<authorList>
<person name="Orlacchio A."/>
<person name="Kawarai T."/>
<person name="Totaro A."/>
<person name="Errico A."/>
<person name="St George-Hyslop P.H."/>
<person name="Rugarli E.I."/>
<person name="Bernardi G."/>
</authorList>
<dbReference type="PubMed" id="15210521"/>
<dbReference type="DOI" id="10.1001/archneur.61.6.849"/>
</citation>
<scope>VARIANT SPG4 SER-386</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2004" name="Eur. J. Neurol." volume="11" first="817" last="824">
<title>Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation.</title>
<authorList>
<person name="Nielsen J.E."/>
<person name="Johnsen B."/>
<person name="Koefoed P."/>
<person name="Scheuer K.H."/>
<person name="Groenbech-Jensen M."/>
<person name="Law I."/>
<person name="Krabbe K."/>
<person name="Noerremoelle A."/>
<person name="Eiberg H."/>
<person name="Soendergaard H."/>
<person name="Dam M."/>
<person name="Rehfeld J.F."/>
<person name="Krarup C."/>
<person name="Paulson O.B."/>
<person name="Hasholt L."/>
<person name="Soerensen S.A."/>
</authorList>
<dbReference type="PubMed" id="15667412"/>
<dbReference type="DOI" id="10.1111/j.1468-1331.2004.00888.x"/>
</citation>
<scope>VARIANT SPG4 GLN-490 DEL</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2004" name="Neurogenetics" volume="5" first="157" last="164">
<title>Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations.</title>
<authorList>
<person name="Svenson I.K."/>
<person name="Kloos M.T."/>
<person name="Gaskell P.C."/>
<person name="Nance M.A."/>
<person name="Garbern J.Y."/>
<person name="Hisanaga S."/>
<person name="Pericak-Vance M.A."/>
<person name="Ashley-Koch A.E."/>
<person name="Marchuk D.A."/>
</authorList>
<dbReference type="PubMed" id="15248095"/>
<dbReference type="DOI" id="10.1007/s10048-004-0186-z"/>
</citation>
<scope>VARIANTS SPG4 VAL-470 AND GLY-562</scope>
<scope>VARIANTS LEU-44 AND GLN-45</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2004" name="Neuromuscul. Disord." volume="14" first="750" last="753">
<title>Two novel mutations in the spastin gene (SPG4) found by DHPLC mutation analysis.</title>
<authorList>
<person name="Falco M."/>
<person name="Scuderi C."/>
<person name="Musumeci S."/>
<person name="Sturnio M."/>
<person name="Neri M."/>
<person name="Bigoni S."/>
<person name="Caniatti L."/>
<person name="Fichera M."/>
</authorList>
<dbReference type="PubMed" id="15482961"/>
<dbReference type="DOI" id="10.1016/j.nmd.2004.05.017"/>
</citation>
<scope>VARIANTS SPG4 GLY-459 AND CYS-460</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2004" name="Neurology" volume="62" first="1875" last="1878">
<title>A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts.</title>
<authorList>
<person name="Orlacchio A."/>
<person name="Gaudiello F."/>
<person name="Totaro A."/>
<person name="Floris R."/>
<person name="St George-Hyslop P.H."/>
<person name="Bernardi G."/>
<person name="Kawarai T."/>
</authorList>
<dbReference type="PubMed" id="15159500"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000125324.32082.D9"/>
</citation>
<scope>VARIANT SPG4 ILE-614</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2004" name="Neurology" volume="63" first="710" last="712">
<title>Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene.</title>
<authorList>
<person name="Chinnery P.F."/>
<person name="Keers S.M."/>
<person name="Holden M.J."/>
<person name="Ramesh V."/>
<person name="Dalton A."/>
</authorList>
<dbReference type="PubMed" id="15326248"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000135346.63675.3E"/>
</citation>
<scope>VARIANT SPG4 LEU-361</scope>
<scope>VARIANT LEU-44</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2006" name="Arch. Neurol." volume="63" first="750" last="755">
<title>Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia.</title>
<authorList>
<person name="Crippa F."/>
<person name="Panzeri C."/>
<person name="Martinuzzi A."/>
<person name="Arnoldi A."/>
<person name="Redaelli F."/>
<person name="Tonelli A."/>
<person name="Baschirotto C."/>
<person name="Vazza G."/>
<person name="Mostacciuolo M.L."/>
<person name="Daga A."/>
<person name="Orso G."/>
<person name="Profice P."/>
<person name="Trabacca A."/>
<person name="D'Angelo M.G."/>
<person name="Comi G.P."/>
<person name="Galbiati S."/>
<person name="Lamperti C."/>
<person name="Bonato S."/>
<person name="Pandolfo M."/>
<person name="Meola G."/>
<person name="Musumeci O."/>
<person name="Toscano A."/>
<person name="Trevisan C.P."/>
<person name="Bresolin N."/>
<person name="Bassi M.T."/>
</authorList>
<dbReference type="PubMed" id="16682546"/>
<dbReference type="DOI" id="10.1001/archneur.63.5.750"/>
</citation>
<scope>VARIANTS SPG4 VAL-195; VAL-406; GLY-493; HIS-499; TRP-503 AND CYS-607</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2006" name="Neuromuscul. Disord." volume="16" first="387" last="390">
<title>Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia.</title>
<authorList>
<person name="Magariello A."/>
<person name="Muglia M."/>
<person name="Patitucci A."/>
<person name="Mazzei R."/>
<person name="Conforti F.L."/>
<person name="Gabriele A.L."/>
<person name="Sprovieri T."/>
<person name="Ungaro C."/>
<person name="Gambardella A."/>
<person name="Mancuso M."/>
<person name="Siciliano G."/>
<person name="Branca D."/>
<person name="Aguglia U."/>
<person name="de Angelis M.V."/>
<person name="Longo K."/>
<person name="Quattrone A."/>
</authorList>
<dbReference type="PubMed" id="16684598"/>
<dbReference type="DOI" id="10.1016/j.nmd.2006.03.009"/>
</citation>
<scope>VARIANT SPG4 LEU-435</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] LEU-423</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2007" name="Eur. J. Neurol." volume="14" first="809" last="814">
<title>Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia.</title>
<authorList>
<person name="Erichsen A.K."/>
<person name="Inderhaug E."/>
<person name="Mattingsdal M."/>
<person name="Eiklid K."/>
<person name="Tallaksen C.M."/>
</authorList>
<dbReference type="PubMed" id="17594340"/>
<dbReference type="DOI" id="10.1111/j.1468-1331.2007.01861.x"/>
</citation>
<scope>VARIANTS SPG4 THR-364 AND HIS-380</scope>
<scope>VARIANTS LEU-44 AND HIS-579</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2010" name="BMC Neurol." volume="10" first="17" last="17">
<title>Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements.</title>
<authorList>
<person name="Braschinsky M."/>
<person name="Tamm R."/>
<person name="Beetz C."/>
<person name="Sachez-Ferrero E."/>
<person name="Raukas E."/>
<person name="Luus S.M."/>
<person name="Gross-Paju K."/>
<person name="Boillot C."/>
<person name="Canzian F."/>
<person name="Metspalu A."/>
<person name="Haldre S."/>
</authorList>
<dbReference type="PubMed" id="20214791"/>
<dbReference type="DOI" id="10.1186/1471-2377-10-17"/>
</citation>
<scope>VARIANTS LEU-44; ILE-162 AND GLY-229</scope>
<scope>VARIANTS SPG4 PHE-426 AND SER-460</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2010" name="BMC Neurol." volume="10" first="89" last="89">
<title>Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia.</title>
<authorList>
<person name="Alvarez V."/>
<person name="Sanchez-Ferrero E."/>
<person name="Beetz C."/>
<person name="Diaz M."/>
<person name="Alonso B."/>
<person name="Corao A.I."/>
<person name="Gamez J."/>
<person name="Esteban J."/>
<person name="Gonzalo J.F."/>
<person name="Pascual-Pascual S.I."/>
<person name="Lopez de Munain A."/>
<person name="Moris G."/>
<person name="Ribacoba R."/>
<person name="Marquez C."/>
<person name="Rosell J."/>
<person name="Marin R."/>
<person name="Garcia-Barcina M.J."/>
<person name="Del Castillo E."/>
<person name="Benito C."/>
<person name="Coto E."/>
</authorList>
<dbReference type="PubMed" id="20932283"/>
<dbReference type="DOI" id="10.1186/1471-2377-10-89"/>
</citation>
<scope>VARIANTS SPG4 THR-287 DEL; LEU-293; ARG-378; HIS-380; PRO-391; 393-LYS--ALA-396 DEL; THR-409; ARG-410; PRO-436; ASN-441; SER-460; ALA-463; PHE-492; GLY-498; ARG-503 INS; GLY-514 AND THR-580</scope>
<scope>VARIANT LEU-328</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2010" name="J. Neurol. Neurosurg. Psych." volume="81" first="1073" last="1078">
<title>Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations.</title>
<authorList>
<person name="de Bot S.T."/>
<person name="van den Elzen R.T."/>
<person name="Mensenkamp A.R."/>
<person name="Schelhaas H.J."/>
<person name="Willemsen M.A."/>
<person name="Knoers N.V."/>
<person name="Kremer H.P."/>
<person name="van de Warrenburg B.P."/>
<person name="Scheffer H."/>
</authorList>
<dbReference type="PubMed" id="20562464"/>
<dbReference type="DOI" id="10.1136/jnnp.2009.201103"/>
</citation>
<scope>VARIANT SPG4 SER-460</scope>
<scope>VARIANTS LEU-44; ILE-162; LYS-356; SER-365; ARG-382; ILE-407; PHE-422; ASN-445; LEU-482; GLU-512 DEL; VAL-534 AND PRO-562</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2011" name="Clin. Genet." volume="79" first="523" last="530">
<title>Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia.</title>
<authorList>
<person name="McCorquodale D.S. III"/>
<person name="Ozomaro U."/>
<person name="Huang J."/>
<person name="Montenegro G."/>
<person name="Kushman A."/>
<person name="Citrigno L."/>
<person name="Price J."/>
<person name="Speziani F."/>
<person name="Pericak-Vance M.A."/>
<person name="Zuchner S."/>
</authorList>
<dbReference type="PubMed" id="20718791"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2010.01501.x"/>
</citation>
<scope>VARIANTS THR-97; ASP-201; SER-314; VAL-360; ALA-464 AND ILE-550</scope>
<scope>VARIANT SPG4 GLY-498</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2011" name="Eur. J. Neurol." volume="18" first="150" last="157">
<title>Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia.</title>
<authorList>
<person name="Battini R."/>
<person name="Fogli A."/>
<person name="Borghetti D."/>
<person name="Michelucci A."/>
<person name="Perazza S."/>
<person name="Baldinotti F."/>
<person name="Conidi M.E."/>
<person name="Ferreri M.I."/>
<person name="Simi P."/>
<person name="Cioni G."/>
</authorList>
<dbReference type="PubMed" id="20550563"/>
<dbReference type="DOI" id="10.1111/j.1468-1331.2010.03102.x"/>
</citation>
<scope>VARIANTS SPG4 LEU-413 AND LYS-454</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2011" name="J. Neurol. Sci." volume="306" first="62" last="65">
<title>Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males.</title>
<authorList>
<person name="Proukakis C."/>
<person name="Moore D."/>
<person name="Labrum R."/>
<person name="Wood N.W."/>
<person name="Houlden H."/>
</authorList>
<dbReference type="PubMed" id="21546041"/>
<dbReference type="DOI" id="10.1016/j.jns.2011.03.043"/>
</citation>
<scope>VARIANTS SPG4 MET-364; LEU-368; GLU-377 AND SER-450</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2012" name="Neurosci. Lett." volume="528" first="42" last="45">
<title>Novel and recurrent spastin mutations in a large series of SPG4 Italian families.</title>
<authorList>
<person name="Nanetti L."/>
<person name="Baratta S."/>
<person name="Panzeri M."/>
<person name="Tomasello C."/>
<person name="Lovati C."/>
<person name="Azzollini J."/>
<person name="Gellera C."/>
<person name="Di Bella D."/>
<person name="Taroni F."/>
<person name="Mariotti C."/>
</authorList>
<dbReference type="PubMed" id="22960362"/>
<dbReference type="DOI" id="10.1016/j.neulet.2012.08.036"/>
</citation>
<scope>VARIANTS SPG4 THR-95; 112-GLU--VAL-616 DEL; 135-GLU--VAL-616 DEL; LEU-399; ARG-406; THR-409; VAL-426; 431-ARG--VAL-616 DEL; CYS-460; TRP-503; ARG-559 AND 562-ARG--VAL-616 DEL</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2013" name="Eur. J. Neurol." volume="20" first="E22" last="E23">
<title>First mutation in the nuclear localization signal sequence of spastin protein identified in a patient with hereditary spastic paraplegia.</title>
<authorList>
<person name="Magariello A."/>
<person name="Tortorella C."/>
<person name="Patitucci A."/>
<person name="Tortelli R."/>
<person name="Liguori M."/>
<person name="Mazzei R."/>
<person name="Conforti F.L."/>
<person name="Citrigno L."/>
<person name="Ungaro C."/>
<person name="Simone I.L."/>
<person name="Muglia M."/>
</authorList>
<dbReference type="PubMed" id="23279441"/>
<dbReference type="DOI" id="10.1111/ene.12000"/>
</citation>
<scope>VARIANT SPG4 HIS-309</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2014" name="BMC Neurol." volume="14" first="216" last="216">
<title>High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia.</title>
<authorList>
<person name="Lan M.Y."/>
<person name="Chang Y.Y."/>
<person name="Yeh T.H."/>
<person name="Lai S.C."/>
<person name="Liou C.W."/>
<person name="Kuo H.C."/>
<person name="Wu Y.R."/>
<person name="Lyu R.K."/>
<person name="Hung J.W."/>
<person name="Chang Y.C."/>
<person name="Lu C.S."/>
</authorList>
<dbReference type="PubMed" id="25421405"/>
<dbReference type="DOI" id="10.1186/s12883-014-0216-x"/>
</citation>
<scope>VARIANTS SPG4 244-ASN--VAL-616 DEL; PRO-461; GLY-555 AND 581-ARG--VAL-616 DEL</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2014" name="J. Clin. Neurol." volume="10" first="257" last="261">
<title>Mutation analysis of SPAST, ATL1, and REEP1 in Korean Patients with Hereditary Spastic Paraplegia.</title>
<authorList>
<person name="Kim T.H."/>
<person name="Lee J.H."/>
<person name="Park Y.E."/>
<person name="Shin J.H."/>
<person name="Nam T.S."/>
<person name="Kim H.S."/>
<person name="Jang H.J."/>
<person name="Semenov A."/>
<person name="Kim S.J."/>
<person name="Kim D.S."/>
</authorList>
<dbReference type="PubMed" id="25045380"/>
<dbReference type="DOI" id="10.3988/jcn.2014.10.3.257"/>
</citation>
<scope>VARIANTS SPG4 44-SER--VAL-616 DEL; 245-SER--VAL-616 DEL; 254-LYS--VAL-616 DEL; GLY-372; LEU-399; ARG-451 DEL; ARG-458; HIS-499 AND 581-ARG--VAL-616 DEL</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2014" name="Parkinsonism Relat. Disord." volume="20" first="845" last="849">
<title>Spastin mutation screening in Chinese patients with pure hereditary spastic paraplegia.</title>
<authorList>
<person name="Wei Q.Q."/>
<person name="Chen Y."/>
<person name="Zheng Z.Z."/>
<person name="Chen X."/>
<person name="Huang R."/>
<person name="Yang Y."/>
<person name="Burgunder J."/>
<person name="Shang H.F."/>
</authorList>
<dbReference type="PubMed" id="24824479"/>
<dbReference type="DOI" id="10.1016/j.parkreldis.2014.04.021"/>
</citation>
<scope>VARIANTS SPG4 PRO-363; LEU-399; VAL-441 AND ARG-595</scope>
</reference>
<comment type="function">
<text evidence="9 16 36 39 47 52 55 60 64 69 75 76">ATP-dependent microtubule severing protein that specifically recognizes and cuts microtubules that are polyglutamylated (PubMed:11809724, PubMed:15716377, PubMed:16219033, PubMed:17389232, PubMed:20530212, PubMed:22637577, PubMed:26875866). Preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold (PubMed:26875866). Severing activity is not dependent on tubulin acetylation or detyrosination (PubMed:26875866). Microtubule severing promotes reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. It is critical for the biogenesis and maintenance of complex microtubule arrays in axons, spindles and cilia. SPAST is involved in abscission step of cytokinesis and nuclear envelope reassembly during anaphase in cooperation with the ESCRT-III complex (PubMed:19000169, PubMed:21310966, PubMed:26040712). Recruited at the midbody, probably by IST1, and participates in membrane fission during abscission together with the ESCRT-III complex (PubMed:21310966). Recruited to the nuclear membrane by IST1 and mediates microtubule severing, promoting nuclear envelope sealing and mitotic spindle disassembly during late anaphase (PubMed:26040712). Required for membrane traffic from the endoplasmic reticulum (ER) to the Golgi and endosome recycling (PubMed:23897888). Recruited by IST1 to endosomes and regulates early endosomal tubulation and recycling by mediating microtubule severing (PubMed:23897888). Probably plays a role in axon growth and the formation of axonal branches (PubMed:15716377).</text>
</comment>
<comment type="function">
<text evidence="74">Isoform 1: Involved in lipid metabolism by regulating the size and distribution of lipid droplets.</text>
</comment>
<comment type="catalytic activity">
<text evidence="9 36 39 44 47 49 64">ATP + H(2)O = ADP + phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="9 64 68">Allosteric enzyme with a cooperative mechanism; at least two neighbor subunits influence each other strongly in spastin hexamers (PubMed:22637577). Microtubule binding promotes cooperative interactions among spastin subunits (PubMed:22637577). ATP-bound enzyme interacts strongly and cooperatively with microtubules; this interaction stimulates ATP hydrolysis (PubMed:23745751).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="36 47 64">0.45 mM for ATP</KM>
<Vmax evidence="36 47 64">1.2 nmol/min/ug enzyme</Vmax>
<text evidence="64">Kinetic parameters shown are for full length enzyme. N-terminally truncated spastin (residues 228-616), which has been shown to exhibit full severing activity, shows a basal ATP turnover rate of 0.78 sec(-1) in the absence of microtubules, a KM of 0.16 mM for ATP, and the ATP turnover rate is extrapolated to 3.83 sec(-1) in the presence of microtubules. ATPase activity shows non-Michaelis-Menten kinetics in the presence of microtubules, but is close to non-cooperative behavior in their absence (PubMed:22637577).</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="9 31 34 36 40 41 44 45 47 51 53 62 64 66 69 70 75">Homohexamer (PubMed:17389232, PubMed:22637577). Mostly monomeric, but assembles into hexameric structure for short periods of time. Oligomerization seems to be a prerequisite for catalytic activity (PubMed:17389232, PubMed:22637577). Binding to ATP in a cleft between two adjacent subunits stabilizes the homohexameric form (PubMed:17389232, PubMed:22637577). Binds to microtubules at least in part via the alpha-tubulin and beta-tubulin tails (PubMed:15269182, PubMed:15716377, PubMed:23272056). The hexamer adopts a ring conformation through which microtubules pass prior to being severed (PubMed:17389232, PubMed:22637577). Does not interact strongly with tubulin heterodimers (PubMed:15269182, PubMed:15716377, PubMed:23272056). Interacts (via MIT domain) with CHMP1B; the interaction is direct (PubMed:15537668, PubMed:18997780). Interacts with SSNA1 (PubMed:15269182). Interacts with ATL1 (PubMed:16339213, PubMed:16815977). Interacts with RTN1 (PubMed:16602018). Interacts with ZFYVE27 (PubMed:16826525, PubMed:23969831). Isoform 1 but not isoform 3 interacts with RTN2 (PubMed:22232211). Interacts with REEP1 (PubMed:20200447). Interacts (via MIT domain) with IST1 (PubMed:23897888, PubMed:26040712).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9 52">Membrane</location>
<topology evidence="9 84">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 41">Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 51 60">Midbody</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 37">Cytoplasm</location>
<location evidence="9 37">Cytoskeleton</location>
<location evidence="9 37">Microtubule organizing center</location>
<location evidence="9 37">Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 36 47 49 52 53">Cytoplasm</location>
<location evidence="9 36 47 49 52 53">Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 16 31 34">Cytoplasm</location>
<location evidence="9 16 31 34">Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 27 38">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 31">Cytoplasm</location>
<location evidence="9 31">Cytoskeleton</location>
<location evidence="9 31">Spindle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 38 53">Cytoplasm</location>
</subcellularLocation>
<text evidence="9 31 37 51 84">Forms a intramembrane hairpin-like structure in the membrane (PubMed:20200447). Localization to the centrosome is independent of microtubules (PubMed:15891913). Localizes to the midbody of dividing cells, and this requires CHMP1B (PubMed:18997780). Enriched in the distal axons and branches of postmitotic neurons (PubMed:15269182).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="52 70">Endoplasmic reticulum membrane</location>
<topology evidence="84">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="75">Nucleus membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="74">Lipid droplet</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="52 53">Cytoplasm</location>
<location evidence="52 53">Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="69">Endosome</location>
</subcellularLocation>
<text evidence="70 75 84">Forms a intramembrane hairpin-like structure in the membrane (PubMed:20200447). Recruited to nuclear membrane by IST1 during late anaphase (PubMed:26040712). Localizes to endoplasmic reticulum tubular network (PubMed:23969831).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location evidence="53 70">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="52 69">Endosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="38 75">Nucleus membrane</location>
</subcellularLocation>
<text evidence="52 75">Constitutes the main endosomal form (PubMed:19000169). Recruited to nuclear membrane by IST1 during late anaphase (PubMed:26040712).</text>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>Q9UBP0-1</id>
<name>1</name>
<name>Long</name>
<name>Long variant 1</name>
<name evidence="80">68 kDa</name>
<name evidence="81">M1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9UBP0-2</id>
<name>2</name>
<name>Long variant 2</name>
<sequence type="described" ref="VSP_000024"/>
</isoform>
<isoform>
<id>Q9UBP0-3</id>
<name>3</name>
<name>Short</name>
<name>Short variant 1</name>
<name evidence="80">60 kDa</name>
<name evidence="81">M87</name>
<sequence type="described" ref="VSP_036650"/>
<text>Produced by alternative promoter usage. May also be produced by alternative initiation at Met-87 of isoform 1. Major isoform.</text>
</isoform>
<isoform>
<id>Q9UBP0-4</id>
<name>4</name>
<name>Short variant 2</name>
<sequence type="described" ref="VSP_036650 VSP_000024"/>
<text>Produced by alternative promoter usage and alternative splicing. May also be produced by alternative initiation at Met-87 of isoform 2.</text>
</isoform>
<text evidence="38 50">Alternative promoter usage of a cryptic promoter in exon 1 can direct the synthesis of N-terminally truncated isoforms, which may also arise from alternative initiation.</text>
</comment>
<comment type="tissue specificity">
<text evidence="10">Expressed in brain, heart, kidney, liver, lung, pancreas, placenta and skeletal muscle. The short isoforms may predominate in brain and spinal cord.</text>
</comment>
<comment type="developmental stage">
<text evidence="10">Expressed in fetal brain, heart, kidney, liver, lung, skeletal muscle, spleen and thymus.</text>
</comment>
<comment type="disease" evidence="10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 28 29 30 32 33 35 36 37 40 42 43 47 48 52 54 56 57 58 59 61 65 67 71 72 73">
<disease id="DI-01036">
<name>Spastic paraplegia 4, autosomal dominant</name>
<acronym>SPG4</acronym>
<description>A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.</description>
<dbReference type="MIM" id="182601"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the AAA ATPase family. Spastin subfamily.</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="http://web.expasy.org/spotlight/back_issues/104"/>
<text>The making of crooked - Issue 104 of April 2009</text>
</comment>
<dbReference type="EC" id="3.6.4.3" evidence="9 36 39 44 47 49 64"/>
<dbReference type="EMBL" id="AJ246001">
<property type="protein sequence ID" value="CAB60141.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ246003">
<property type="protein sequence ID" value="CAB60208.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB029006">
<property type="protein sequence ID" value="BAA83035.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471053">
<property type="protein sequence ID" value="EAX00462.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC150260">
<property type="protein sequence ID" value="AAI50261.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1778.1">
<molecule id="Q9UBP0-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1779.1">
<molecule id="Q9UBP0-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055761.2">
<molecule id="Q9UBP0-1"/>
<property type="nucleotide sequence ID" value="NM_014946.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_955468.1">
<molecule id="Q9UBP0-2"/>
<property type="nucleotide sequence ID" value="NM_199436.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.468091"/>
<dbReference type="PDB" id="3EAB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D/E/F=112-196"/>
</dbReference>
<dbReference type="PDB" id="3VFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=228-616"/>
</dbReference>
<dbReference type="PDBsum" id="3EAB"/>
<dbReference type="PDBsum" id="3VFD"/>
<dbReference type="ProteinModelPortal" id="Q9UBP0"/>
<dbReference type="SMR" id="Q9UBP0"/>
<dbReference type="BioGrid" id="112562">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="DIP" id="DIP-38418N"/>
<dbReference type="IntAct" id="Q9UBP0">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000320885"/>
<dbReference type="iPTMnet" id="Q9UBP0"/>
<dbReference type="PhosphoSitePlus" id="Q9UBP0"/>
<dbReference type="BioMuta" id="SPAST"/>
<dbReference type="DMDM" id="12230611"/>
<dbReference type="EPD" id="Q9UBP0"/>
<dbReference type="PaxDb" id="Q9UBP0"/>
<dbReference type="PeptideAtlas" id="Q9UBP0"/>
<dbReference type="PRIDE" id="Q9UBP0"/>
<dbReference type="Ensembl" id="ENST00000315285">
<molecule id="Q9UBP0-1"/>
<property type="protein sequence ID" value="ENSP00000320885"/>
<property type="gene ID" value="ENSG00000021574"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000345662">
<molecule id="Q9UBP0-2"/>
<property type="protein sequence ID" value="ENSP00000340817"/>
<property type="gene ID" value="ENSG00000021574"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000615843">
<molecule id="Q9UBP0-1"/>
<property type="protein sequence ID" value="ENSP00000480893"/>
<property type="gene ID" value="ENSG00000021574"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000621856">
<molecule id="Q9UBP0-3"/>
<property type="protein sequence ID" value="ENSP00000482496"/>
<property type="gene ID" value="ENSG00000021574"/>
</dbReference>
<dbReference type="GeneID" id="6683"/>
<dbReference type="KEGG" id="hsa:6683"/>
<dbReference type="UCSC" id="uc002roc.4">
<molecule id="Q9UBP0-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6683"/>
<dbReference type="DisGeNET" id="6683"/>
<dbReference type="GeneCards" id="SPAST"/>
<dbReference type="GeneReviews" id="SPAST"/>
<dbReference type="HGNC" id="HGNC:11233">
<property type="gene designation" value="SPAST"/>
</dbReference>
<dbReference type="HPA" id="HPA017311"/>
<dbReference type="MalaCards" id="SPAST"/>
<dbReference type="MIM" id="182601">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604277">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UBP0"/>
<dbReference type="OpenTargets" id="ENSG00000021574"/>
<dbReference type="Orphanet" id="100985">
<property type="disease" value="Autosomal dominant spastic paraplegia type 4"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36063"/>
<dbReference type="eggNOG" id="KOG0740">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0464">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00570000078874"/>
<dbReference type="HOGENOM" id="HOG000225146"/>
<dbReference type="HOVERGEN" id="HBG108502"/>
<dbReference type="InParanoid" id="Q9UBP0"/>
<dbReference type="KO" id="K13254"/>
<dbReference type="OMA" id="GNPDGDR"/>
<dbReference type="OrthoDB" id="EOG091G0Q8J"/>
<dbReference type="PhylomeDB" id="Q9UBP0"/>
<dbReference type="TreeFam" id="TF105014"/>
<dbReference type="BRENDA" id="3.6.4.3">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9UBP0"/>
<dbReference type="ChiTaRS" id="SPAST">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9UBP0"/>
<dbReference type="GeneWiki" id="Spastin"/>
<dbReference type="GenomeRNAi" id="6683"/>
<dbReference type="PRO" id="PR:Q9UBP0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000021574"/>
<dbReference type="CleanEx" id="HS_SPAST"/>
<dbReference type="ExpressionAtlas" id="Q9UBP0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UBP0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:1904115">
<property type="term" value="C:axon cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0071782">
<property type="term" value="C:endoplasmic reticulum tubular network"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid particle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005874">
<property type="term" value="C:microtubule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005815">
<property type="term" value="C:microtubule organizing center"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0043014">
<property type="term" value="F:alpha-tubulin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048487">
<property type="term" value="F:beta-tubulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008568">
<property type="term" value="F:microtubule-severing ATPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008089">
<property type="term" value="P:anterograde axonal transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019896">
<property type="term" value="P:axonal transport of mitochondrion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032506">
<property type="term" value="P:cytokinetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031122">
<property type="term" value="P:cytoplasmic microtubule organization"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006888">
<property type="term" value="P:ER to Golgi vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010458">
<property type="term" value="P:exit from mitosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090148">
<property type="term" value="P:membrane fission"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008152">
<property type="term" value="P:metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001578">
<property type="term" value="P:microtubule bundle formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051013">
<property type="term" value="P:microtubule severing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000281">
<property type="term" value="P:mitotic cytokinesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051228">
<property type="term" value="P:mitotic spindle disassembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031468">
<property type="term" value="P:nuclear envelope reassembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032467">
<property type="term" value="P:positive regulation of cytokinesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034214">
<property type="term" value="P:protein hexamerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="HAMAP" id="MF_03021">
<property type="entry name" value="Spastin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003593">
<property type="entry name" value="AAA+_ATPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR003959">
<property type="entry name" value="ATPase_AAA_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR003960">
<property type="entry name" value="ATPase_AAA_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR007330">
<property type="entry name" value="MIT"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR017179">
<property type="entry name" value="Spastin"/>
</dbReference>
<dbReference type="InterPro" id="IPR015415">
<property type="entry name" value="Vps4_C"/>
</dbReference>
<dbReference type="Pfam" id="PF00004">
<property type="entry name" value="AAA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09336">
<property type="entry name" value="Vps4_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037338">
<property type="entry name" value="Spastin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00382">
<property type="entry name" value="AAA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00745">
<property type="entry name" value="MIT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00674">
<property type="entry name" value="AAA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0021">Allosteric enzyme</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0890">Hereditary spastic paraplegia</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0551">Lipid droplet</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0493">Microtubule</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Spastin" id="PRO_0000084763">
<location>
<begin position="1"/>
<end position="616"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="9 84">
<location>
<begin position="1"/>
<end position="56"/>
</location>
</feature>
<feature type="intramembrane region" description="Helical" evidence="9 84">
<location>
<begin position="57"/>
<end position="77"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="9 84">
<location>
<begin position="78"/>
<end position="616"/>
</location>
</feature>
<feature type="domain" description="MIT" evidence="8">
<location>
<begin position="120"/>
<end position="195"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9 83">
<location>
<begin position="382"/>
<end position="389"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with RTN1" evidence="41">
<location>
<begin position="1"/>
<end position="300"/>
</location>
</feature>
<feature type="region of interest" description="Required for midbody localization" evidence="51">
<location>
<begin position="1"/>
<end position="194"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with ATL1" evidence="40 44">
<location>
<begin position="1"/>
<end position="80"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization" evidence="27">
<location>
<begin position="1"/>
<end position="50"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with SSNA1 and microtubules" evidence="31">
<location>
<begin position="50"/>
<end position="87"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with CHMP1B" evidence="51">
<location>
<begin position="112"/>
<end position="196"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with microtubules" evidence="31">
<location>
<begin position="114"/>
<end position="200"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for microtubule severing" evidence="31">
<location>
<begin position="228"/>
<end position="616"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with microtubules and microtubule severing" evidence="31">
<location>
<begin position="270"/>
<end position="328"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with microtubules" evidence="66">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="9 27">
<location>
<begin position="4"/>
<end position="11"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="9 38">
<location>
<begin position="59"/>
<end position="67"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="9 27">
<location>
<begin position="309"/>
<end position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7">
<location>
<position position="245"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5 7">
<location>
<position position="268"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="306"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="597"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_036650" evidence="82">
<location>
<begin position="1"/>
<end position="86"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_000024" evidence="77 79">
<location>
<begin position="197"/>
<end position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075827" evidence="72">
<location>
<begin position="44"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; acts as a disease modifier; patients carrying a mutated allele of spastin and L-44 on the other allele are affected by severe spastic paraplegia with an early age of onset; may decrease the activity of the alternative promoter which directs the synthesis of isoform 3 and isoform 4; dbSNP:rs121908515." id="VAR_010194" evidence="12 30 32 48 50 54 57">
<original>S</original>
<variation>L</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; acts as a disease modifier; patients carrying a mutated allele of spastin and Q-45 on the other allele are affected by severe spastic paraplegia with an early age of onset; dbSNP:rs121908517." id="VAR_027205" evidence="30">
<original>P</original>
<variation>Q</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075828" evidence="65">
<original>A</original>
<variation>T</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance; dbSNP:rs372005558." id="VAR_067628" evidence="58">
<original>P</original>
<variation>T</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075829" evidence="65">
<location>
<begin position="112"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075830" evidence="65">
<location>
<begin position="135"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance; dbSNP:rs141944844." id="VAR_067563" evidence="54 57">
<original>V</original>
<variation>I</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_026758" evidence="42">
<original>L</original>
<variation>V</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067629" evidence="58">
<original>V</original>
<variation>D</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_067630" evidence="54">
<original>S</original>
<variation>G</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075831" evidence="73">
<location>
<begin position="244"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075832" evidence="72">
<location>
<begin position="245"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075833" evidence="72">
<location>
<begin position="254"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067631" evidence="59">
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs773193617." id="VAR_067632" evidence="59">
<original>P</original>
<variation>L</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs202152835." id="VAR_075834" evidence="67">
<original>R</original>
<variation>H</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067633" evidence="58">
<original>L</original>
<variation>S</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067634" evidence="59">
<original>I</original>
<variation>L</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; abrogates ATPase activity and promotes microtubule binding; dbSNP:rs121908513." id="VAR_019448" evidence="22 36">
<original>I</original>
<variation>K</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; promotes microtubule binding." id="VAR_027206" evidence="20 36">
<original>Q</original>
<variation>K</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067564" evidence="57">
<original>E</original>
<variation>K</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067635" evidence="58">
<original>L</original>
<variation>V</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027207" evidence="32">
<original>P</original>
<variation>L</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs121908509." id="VAR_010195" evidence="10 11">
<original>S</original>
<variation>C</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075835" evidence="71">
<original>L</original>
<variation>P</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075836" evidence="61">
<original>R</original>
<variation>M</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067636" evidence="48">
<original>R</original>
<variation>T</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067565" evidence="57">
<original>P</original>
<variation>S</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075837" evidence="61">
<original>F</original>
<variation>L</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; promotes microtubule binding and the formation of thick microtubule bundles." id="VAR_027208" evidence="11 16">
<original>G</original>
<variation>R</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075838" evidence="72">
<original>R</original>
<variation>G</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075839" evidence="61">
<original>G</original>
<variation>E</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_019439" evidence="26">
<original>L</original>
<variation>Q</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067637" evidence="59">
<original>L</original>
<variation>R</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067638" evidence="48 59">
<original>L</original>
<variation>H</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; promotes microtubule binding and the formation of thick microtubule bundles." id="VAR_027209" evidence="11 16">
<original>F</original>
<variation>C</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067566" evidence="57">
<original>G</original>
<variation>R</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; abrogates ATPase activity, promotes microtubule binding and the formation of thick microtubule bundles." id="VAR_027210" evidence="11 16 36">
<original>N</original>
<variation>K</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs121908514." id="VAR_019440" evidence="29">
<original>N</original>
<variation>S</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; abrogates ATPase activity, promotes microtubule binding and the formation of thick microtubule bundles and impairs traffic from the ER to Golgi." id="VAR_027211" evidence="11 16 20 36 37 40 52">
<original>K</original>
<variation>R</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs797044850." id="VAR_019441" evidence="26">
<original>M</original>
<variation>V</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067639" evidence="59">
<original>L</original>
<variation>P</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067640" evidence="59">
<location>
<begin position="393"/>
<end position="396"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027212" evidence="17 65 71 72">
<original>S</original>
<variation>L</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_019449" evidence="21">
<location>
<position position="404"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075840" evidence="65">
<original>I</original>
<variation>R</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs587777757." id="VAR_026759" evidence="42">
<original>I</original>
<variation>V</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067567" evidence="57">
<original>S</original>
<variation>I</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_019450" evidence="19">
<original>S</original>
<variation>R</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067641" evidence="59 65">
<original>A</original>
<variation>T</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067642" evidence="59">
<original>S</original>
<variation>R</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067568" evidence="56">
<original>S</original>
<variation>L</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067569" evidence="57">
<original>L</original>
<variation>F</variation>
<location>
<position position="422"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035902" evidence="46">
<original>V</original>
<variation>L</variation>
<location>
<position position="423"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_010196" evidence="12">
<original>R</original>
<variation>G</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067643" evidence="54">
<original>L</original>
<variation>F</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; promotes microtubule binding and the formation of thick microtubule bundles." id="VAR_027213" evidence="11 16 17 65">
<original>L</original>
<variation>V</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075841" evidence="65">
<location>
<begin position="431"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027214" evidence="43">
<original>P</original>
<variation>L</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027215" evidence="14">
<original>S</original>
<variation>F</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067644" evidence="59">
<original>S</original>
<variation>P</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs121908512." id="VAR_027216" evidence="13">
<original>D</original>
<variation>G</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067645" evidence="59">
<original>D</original>
<variation>N</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075842" evidence="71">
<original>D</original>
<variation>V</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067570" evidence="57">
<original>S</original>
<variation>N</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; abrogates binding to the tail of beta-3-tubulin, abolishes microtubule severing and promotes the formation of thick microtubule bundles; dbSNP:rs121908510." id="VAR_010197" evidence="10 11 16 47">
<original>C</original>
<variation>Y</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075843" evidence="61">
<original>R</original>
<variation>S</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075844" evidence="72">
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067571" evidence="56">
<original>E</original>
<variation>K</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075845" evidence="72">
<original>S</original>
<variation>R</variation>
<location>
<position position="458"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027217" evidence="33">
<original>R</original>
<variation>G</variation>
<location>
<position position="459"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027218" evidence="33 65">
<original>R</original>
<variation>C</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; promotes microtubule binding and the formation of thick microtubule bundles." id="VAR_027219" evidence="11 16">
<original>R</original>
<variation>L</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067572" evidence="54 57 59">
<original>R</original>
<variation>S</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075846" evidence="73">
<original>L</original>
<variation>P</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067646" evidence="59">
<original>T</original>
<variation>A</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067647" evidence="58">
<original>E</original>
<variation>A</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs28939368." id="VAR_027220" evidence="30">
<original>D</original>
<variation>V</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067573" evidence="57">
<original>V</original>
<variation>L</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027221" evidence="23">
<original>A</original>
<variation>V</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027222" evidence="17">
<original>P</original>
<variation>L</variation>
<location>
<position position="489"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075847" evidence="35">
<location>
<begin position="490"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067648" evidence="59">
<original>L</original>
<variation>F</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_026760" evidence="42">
<original>D</original>
<variation>G</variation>
<location>
<position position="493"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067649" evidence="58 59">
<original>R</original>
<variation>G</variation>
<location>
<position position="498"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; abrogates ATPase activity, promotes microtubule binding and the formation of thick microtubule bundles; dbSNP:rs121908511." id="VAR_010198" evidence="10 11 15 16 20 36">
<original>R</original>
<variation>C</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_026761" evidence="42 72">
<original>R</original>
<variation>H</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_019442" evidence="24">
<original>R</original>
<variation>L</variation>
<location>
<position position="503"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067650" evidence="59">
<original>R</original>
<variation>RR</variation>
<location>
<position position="503"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs864622162." id="VAR_026762" evidence="42 65">
<original>R</original>
<variation>W</variation>
<location>
<position position="503"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027223" evidence="18">
<original>E</original>
<variation>D</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067574" evidence="57">
<location>
<position position="512"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067651" evidence="59">
<original>R</original>
<variation>G</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_019443" evidence="26">
<location>
<position position="515"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_019444" evidence="25">
<original>L</original>
<variation>P</variation>
<location>
<position position="534"/>
</location>
</feature>
<feature type="sequence variant" description="Found at homozygosity in two children with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067575" evidence="57">
<original>L</original>
<variation>V</variation>
<location>
<position position="534"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067652" evidence="58">
<original>T</original>
<variation>I</variation>
<location>
<position position="550"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; requires 2 nucleotide substitutions." id="VAR_019451" evidence="19">
<original>A</original>
<variation>Y</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075848" evidence="73">
<original>D</original>
<variation>G</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_027224" evidence="11">
<original>D</original>
<variation>N</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; promotes microtubule binding and the formation of thick microtubule bundles." id="VAR_027225" evidence="11 16">
<original>A</original>
<variation>V</variation>
<location>
<position position="556"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs864622179." id="VAR_027226" evidence="14 17">
<original>G</original>
<variation>D</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075849" evidence="65">
<original>G</original>
<variation>R</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075850" evidence="65">
<location>
<begin position="562"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs121908518." id="VAR_027227" evidence="15 30">
<original>R</original>
<variation>G</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with hereditary spastic paraplegia; unknown pathological significance." id="VAR_067576" evidence="57">
<original>R</original>
<variation>P</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; dbSNP:rs863224923." id="VAR_027228" evidence="17">
<original>R</original>
<variation>Q</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with hereditary spastic paraplegia; unknown pathological significance; dbSNP:rs144594804." id="VAR_067653" evidence="48">
<original>N</original>
<variation>H</variation>
<location>
<position position="579"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_067654" evidence="59">
<original>I</original>
<variation>T</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075851" evidence="72 73">
<location>
<begin position="581"/>
<end position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_010199" evidence="12">
<original>D</original>
<variation>H</variation>
<location>
<position position="584"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_075852" evidence="71">
<original>S</original>
<variation>R</variation>
<location>
<position position="595"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_026763" evidence="42">
<original>W</original>
<variation>C</variation>
<location>
<position position="607"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4; variant form with congenital arachnoid cysts." id="VAR_019445" evidence="28">
<original>T</original>
<variation>I</variation>
<location>
<position position="614"/>
</location>
</feature>
<feature type="sequence variant" description="In SPG4." id="VAR_019452" evidence="19">
<original>T</original>
<variation>I</variation>
<location>
<position position="615"/>
</location>
</feature>
<feature type="mutagenesis site" description="Cytoplasmic and nuclear." evidence="38">
<original>M</original>
<variation>V</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes localization to lipid droplets." evidence="74">
<original>R</original>
<variation>G</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect localization to lipid droplets." evidence="74">
<original>RFSR</original>
<variation>GFSG</variation>
<location>
<begin position="81"/>
<end position="84"/>
</location>
</feature>
<feature type="mutagenesis site" description="Exclusively cytoplasmic." evidence="38">
<original>M</original>
<variation>V</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to CHMP1B. Impairs midbody localization; when associated with D-124." evidence="51">
<original>H</original>
<variation>D</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to CHMP1B." evidence="51">
<original>F</original>
<variation>A</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to CHMP1B. Impairs midbody localization; when associated with D-120." evidence="51">
<original>F</original>
<variation>D</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of microtubule-binding." evidence="66">
<original>KKK</original>
<variation>QQQ</variation>
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ATPase activity and abolishes microtubule severing." evidence="36">
<original>K</original>
<variation>A</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to the tail of alpha-tubulin and beta-3-tubulin, impairs ATPase activity and abolishes microtubule severing." evidence="47">
<original>Y</original>
<variation>A</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ATP hydrolysis, abolishes microtubule severing, stabilizes the homohexameric form, and promotes microtubule binding and redistribution from the endosome to microtubules." evidence="36 44 47 49 63 64 66 68">
<original>E</original>
<variation>Q</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ATPase activity." evidence="68">
<original>C</original>
<variation>A</variation>
<variation>G</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect ATPase activity." evidence="68">
<original>C</original>
<variation>S</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to the tail of alpha-tubulin and beta-3-tubulin, impairs ATPase activity and abolishes microtubule severing." evidence="47">
<original>R</original>
<variation>G</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to the tail of alpha-tubulin and beta-3-tubulin and abolishes microtubule severing." evidence="47">
<original>A</original>
<variation>E</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="112"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="146"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="169"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="341"/>
<end position="343"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="348"/>
<end position="357"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="359"/>
<end position="363"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="365"/>
<end position="367"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="370"/>
<end position="372"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="376"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="388"/>
<end position="398"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="402"/>
<end position="406"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="420"/>
<end position="432"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="433"/>
<end position="441"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="443"/>
<end position="446"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="458"/>
<end position="472"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="480"/>
<end position="487"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="489"/>
<end position="491"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="494"/>
<end position="497"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="502"/>
<end position="505"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="511"/>
<end position="522"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="531"/>
<end position="540"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="541"/>
<end position="543"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="546"/>
<end position="556"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="559"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="573"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="582"/>
<end position="591"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="598"/>
<end position="610"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EAB"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VFD"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="HAMAP-Rule" id="MF_03021"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10610178"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10699187"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11015453"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11039577"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11087788"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11309678"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11809724"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11843700"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11985387"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12124993"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12161613"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12163196"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12202986"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12460147"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12552568"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939659"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14732620"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15147984"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15159500"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15210521"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15248095"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15269182"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15326248"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15482961"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15537668"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15667412"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15716377"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15891913"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16026783"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16219033"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16339213"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16602018"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16682546"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16684598"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16815977"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16826525"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17389232"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17594340"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18410514"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18613979"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18997780"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19000169"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20200447"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20214791"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20530212"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20550563"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20562464"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20718791"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20932283"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21310966"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21546041"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22232211"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22446388"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22637577"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22960362"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23272056"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23279441"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23745751"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23897888"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23969831"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24824479"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25045380"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25421405"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25875445"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26040712"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26875866"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10470851"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10610178"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19000169"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20200447"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000305"/>
<evidence key="83" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15716377"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20200447"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:11233"/>
</source>
</evidence>
<sequence length="616" mass="67197" checksum="75E5FC5787132B4C" modified="2000-05-01" version="1">
MNSPGGRGKKKGSGGASNPVPPRPPPPCLAPAPPAAGPAPPPESPHKRNLYYFSYPLFVG
FALLRLVAFHLGLLFVWLCQRFSRALMAAKRSSGAAPAPASASAPAPVPGGEAERVRVFH
KQAFEYISIALRIDEDEKAGQKEQAVEWYKKGIEELEKGIAVIVTGQGEQCERARRLQAK
MMTNLVMAKDRLQLLEKMQPVLPFSKSQTDVYNDSTNLACRNGHLQSESGAVPKRKDPLT
HTSNSLPRSKTVMKTGSAGLSGHHRAPSYSGLSMVSGVKQGSGPAPTTHKGTPKTNRTNK
PSTPTTATRKKKDLKNFRNVDSNLANLIMNEIVDNGTAVKFDDIAGQDLAKQALQEIVIL
PSLRPELFTGLRAPARGLLLFGPPGNGKTMLAKAVAAESNATFFNISAASLTSKYVGEGE
KLVRALFAVARELQPSIIFIDEVDSLLCERREGEHDASRRLKTEFLIEFDGVQSAGDDRV
LVMGATNRPQELDEAVLRRFIKRVYVSLPNEETRLLLLKNLLCKQGSPLTQKELAQLARM
TDGYSGSDLTALAKDAALGPIRELKPEQVKNMSASEMRNIRLSDFTESLKKIKRSVSPQT
LEAYIRWNKDFGDTTV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>